National Comprehensive Cancer Network

About NCCN

NCCN GUIDELINES AND NCCN COMPENDIUM UPDATED

NCCN Flash Update sent July 21, 2014

 

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium®) for Non-Hodgkin’s Lymphomas. These NCCN Guidelines® are currently available as Version 3.2014.

  • Peripheral T-Cell Lymphomas
    • For both candidate and non-candidate for transplant, a new second-line therapy “belinostat” was added with a category 2B recommendation. (TCEL-B 1 of 2)

 

*For your reference, the previous update (Version 2.2014) to the NCCN Guidelines for Non-Hodgkin’s Lymphomas, distributed on March 28, 2014, is available at the following link:

http://www.nccn.org/professionals/physician_gls/pdf/nhl.pdf#Page=4

 

For the complete updated versions of the NCCN Guidelines, the NCCN Compendium®, and the NCCN Chemotherapy Order Templates (NCCN Templates®), please visit NCCN.org.

To access the NCCN Biomarkers Compendium®, please visit NCCN.org/biomarkers.

To view the NCCN Guidelines for Patients®, please visit NCCN.org/patients.

Free NCCN Guidelines apps iPhone, iPad, and Android devices are now available! Visit NCCN.org/apps